Pain perception in schizophrenia: influence of neuropeptides, cognitive disorders, and negative symptoms

Código QR

Pain perception in schizophrenia: influence of neuropeptides, cognitive disorders, and negative symptoms

Małgorzata Urban-Kowalczyk,1 Justyna Pigońska,2 Janusz Śmigielski3 1Department of Affective and Psychotic Disorders, Medical University of Łódź, Łódź, Poland; 2Department of Neurology and Movement Disorders, Medical University of Łódź, Łódź, Poland; 3Depa...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Urban-Kowalczyk M, Pigońska J, Śmigielski J
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2015
Materias:	Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429
Acceso en línea:	https://doaj.org/article/e6ba1436f29d48a2b304e84ef167c01a
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Odor perception and hedonics in chronic schizophrenia and in first episode psychosis
por: Urban-Kowalczyk M, et al.
Publicado: (2019)

Neuropsychiatric symptoms and celiac disease
por: Urban-Kowalczyk M, et al.
Publicado: (2014)

Comparison of beta-endorphin and CGRP levels before and after treatment for severe schizophrenia
por: Urban-Kowalczyk M, et al.
Publicado: (2016)

The Relationship Between Antipsychotic Treatment and Plasma β-Endorphin Concentration in Patients with Schizophrenia
por: Urban-Kowalczyk M, et al.
Publicado: (2021)

The Relationship Between Course of Illness and β-Endorphin Plasma Levels in Patients with Schizophrenia
por: Urban-Kowalczyk M, et al.
Publicado: (2020)

Prevalence of metabolic syndrome according to the presence of negative symptoms in patients with schizophrenia
por: Sicras-Mainar A, et al.
Publicado: (2014)

Thought disorder measured as random speech structure classifies negative symptoms and schizophrenia diagnosis 6 months in advance
por: Natália B. Mota, et al.
Publicado: (2017)

Cognitive dysfunction and negative symptoms in patients with schizophrenia and their first-degree relatives from simplex and multiplex families
por: Zhang Z, et al.
Publicado: (2018)

Avolition as the core negative symptom in schizophrenia: relevance to pharmacological treatment development
por: Gregory P. Strauss, et al.
Publicado: (2021)

Negative Symptoms of Schizophrenia: New Prospects of Cariprazine Treatment
por: Aleksandr M. Reznik, et al.
Publicado: (2020)

Tobacco smoking in treatment-resistant schizophrenia patients is associated with impaired cognitive functioning, more severe negative symptoms, and poorer social adjustment
por: Iasevoli F, et al.
Publicado: (2013)

Direct and indirect effects of paliperidone extended-release tablets on negative symptoms of schizophrenia
por: Ibrahim Turkoz, et al.
Publicado: (2008)

Association of Per3 length polymorphism with bipolar I disorder and schizophrenia
por: Karthikeyan R, et al.
Publicado: (2014)

Pharmacological treatment of negative symptoms in schizophrenia: update and proposal of a clinical algorithm
por: Cerveri G, et al.
Publicado: (2019)

Asenapine monotherapy in the acute treatment of both schizophrenia and bipolar&nbsp;I disorder
por: Delia Bishara, et al.
Publicado: (2009)

Metacognitive Beliefs, Cognitive Functioning, Psychiatric Symptoms and Empathy in People with Schizophrenia
por: Chuang SP, et al.
Publicado: (2021)

Negative Symptoms in Schizophrenia: A Review and Clinical Guide for Recognition, Assessment, and Treatment
por: Correll CU, et al.
Publicado: (2020)

Sleep and cognitive problems in patients with attention-deficit hyperactivity disorder
por: Lee HK, et al.
Publicado: (2014)

Repetitive transcranial magnetic stimulation as an adjunctive treatment for negative symptoms and cognitive impairment in patients with schizophrenia: a randomized, double-blind, sham-controlled trial
por: Zhuo K, et al.
Publicado: (2019)

Telomere length in blood cells is related to the chronicity, severity, and recurrence rate of schizophrenia
por: Pawelczyk T, et al.
Publicado: (2015)

Efficacy of low-dose D2/D3 partial agonist pramipexole on neuroleptic-induced extrapyramidal symptoms and symptoms of schizophrenia: a stage-1 open-label pilot study
por: Weng JJ, et al.
Publicado: (2019)

Influence of CFH gene on symptom severity of schizophrenia
por: Zhang C, et al.
Publicado: (2017)

Effectiveness of amisulpride in Chinese patients with predominantly negative symptoms of schizophrenia: a subanalysis of the ESCAPE study
por: Liang Y, et al.
Publicado: (2017)

The role of family therapy in the management of schizophrenia: challenges and solutions
por: Caqueo-Urízar A, et al.
Publicado: (2015)

Antipsychotics for negative and positive symptoms of schizophrenia: dose-response meta-analysis of randomized controlled acute phase trials
por: Michel Sabe, et al.
Publicado: (2021)

Intermittent theta burst stimulation for negative symptoms of schizophrenia—A double-blind, sham-controlled pilot study
por: Rémy Bation, et al.
Publicado: (2021)

Cognitive impairment in schizophrenia: relationships with cortical thickness in fronto-temporal regions, and dissociability from symptom severity
por: Erkan Alkan, et al.
Publicado: (2021)

Case Report: Cariprazine Efficacy in Young Patients Diagnosed With Schizophrenia With Predominantly Negative Symptoms
por: Octavian Vasiliu
Publicado: (2021)

EEG microstates changes in schizophrenia patients with negative symptoms after accelerated repetitive transcranial magnetic stimulation
por: Tomas Sverak, et al.
Publicado: (2021)

Self-perception of mental illness, and subjective and objective cognitive functioning in people with schizophrenia
por: Chuang SP, et al.
Publicado: (2019)

Patients with schizophrenia or schizoaffective disorder who receive multiple electroconvulsive therapy sessions: characteristics, indications, and results
por: Iancu I, et al.
Publicado: (2015)

Association Between Autistic Symptoms and Self-Stigma in Patients with Schizophrenia Spectrum Disorders
por: Komatsu H, et al.
Publicado: (2020)

Comparing the influences of age and disease on the Brief Assessment of Cognition in Schizophrenia in Japanese patients with schizophrenia
por: Kaneda A, et al.
Publicado: (2013)

Use of second-generation antipsychotics in the acute inpatient management of schizophrenia in the Middle East
por: Alkhadhari S, et al.
Publicado: (2015)

Dynamic face processing impairments are associated with cognitive and positive psychotic symptoms across psychiatric disorders
por: Hayley Darke, et al.
Publicado: (2021)

Below and beyond the recognition of emotional facial expressions in alcohol dependence: from basic perception to social cognition
por: D’Hondt F, et al.
Publicado: (2014)

Anti-NMDA receptor antibodies in patients with a first episode of schizophrenia
por: Masopust J, et al.
Publicado: (2015)

Defensive function of persecutory delusion and discrepancy between explicit and implicit self-esteem in schizophrenia: study using the Brief Implicit Association Test
por: Nakamura M, et al.
Publicado: (2014)

Association of metabotropic glutamate receptor 3 gene polymorphisms with schizophrenia risk: evidence from a meta-analysis
por: Yang X, et al.
Publicado: (2015)

Measuring negative symptoms in patients with schizophrenia: reliability and validity of the Korean version of the Motivation and Pleasure Scale-Self-Report
por: Kim JS, et al.
Publicado: (2016)